◦ Sinopharm
Shanghai pushes COVID-19 booster shots as community cases resurface - Shanghai Metro News
Metro

Shanghai pushes COVID-19 booster shots as community cases resurface

People over 18 years old who are fully vaccinated with one of the three inactivated vaccines produced by Sinopharm and Sinovac Biotech can get a protein subunit COVID 19 vaccine made...
Citizens given more choices of vaccine type for COVID-19 booster shot - Shanghai Metro News
Metro

Citizens given more choices of vaccine type for COVID-19 booster shot

They are targeting people over 18 years old who are fully vaccinated with one of the three inactivated vaccines produced by Sinopharm and Sinovac Biotech.
WHO authorizes China's CanSinoBIO COVID-19 vaccine - COVID-19 news
COVID-19

WHO authorizes China's CanSinoBIO COVID-19 vaccine

It is the third Chinese made vaccine to be approved by the WHO after Sinovac and Sinopharm.
China's Omicron vaccine expected to complete clinical trials in 3-4 months - China Nation News
Nation

China's Omicron vaccine expected to complete clinical trials in 3-4 months

said Zhang Yuntao chief scientist and vice president of vaccine developer China National Biotec Group CNBG affiliated with Sinopharm during an online press conference.
Chinese vaccine against Omicron variants to undergo clinical trials - China Nation News
Nation

Chinese vaccine against Omicron variants to undergo clinical trials

The vaccine developed by the China National Biotec Group affiliated with Sinopharm has been under research since December 2021 the company said.
Insurance firms launch measures to help clients, residents - COVID-19 news
COVID-19

Insurance firms launch measures to help clients, residents

To better meet the medication needs of the elderly and people suffering from various chronic diseases Ping An Health Insurance launched a guardian program in collaboration with Sinopharm...
First Shanghai-made one-shot COVID-19 vaccine launched - Shanghai Metro News
Metro

First Shanghai-made one-shot COVID-19 vaccine launched

Shots from Sinovac and Sinopharm the first two COVID 19 vaccines approved in China have shown efficacy of between 50 percent and 91 percent.
China to dispatch experts of traditional Chinese medicine to Cambodia to fight COVID-19 - China Nation News
Nation

China to dispatch experts of traditional Chinese medicine to Cambodia to fight COVID-19

Most of the vaccines used in the countrys inoculation campaign are Chinas Sinovac and Sinopharm.
Sinopharm, Sinovac vaccines prevent severe hospitalization from Omicron: report - World News
World

Sinopharm, Sinovac vaccines prevent severe hospitalization from Omicron: report

China's Sinopharm and Sinovac COVID-19 vaccines protect against "severe hospitalization" caused by the Omicron variant.
China's vaccine donations, co-productions light up hope of winning fight against COVID-19 in Mideast - China Nation News
Nation

China's vaccine donations, co-productions light up hope of winning fight against COVID-19 in Mideast

Morocco started its nationwide vaccination campaign on Jan. 28 following the arrival of Chinas Sinopharm vaccines. Many other countries in the Middle East including Egypt Iraq Sudan...
Top